Tear biomarkers play an increasingly important role in the field of predictive, preventive, and personalized medicine. Several molecules have been suggested as promising biomarkers in ocular diseases, particularly in dry eye disease. However, tear molecules have also been studied in systemic diseases, with or without apparent ocular involvement. This Special Issue of Applied Sciences on “Potential Biomarkers in Tears”, aims to present an overview of the current knowledge in this field by bringing together studies about potential biomarkers in tears and their applications. [Texto extraído del artículo de Amalia Enríquez de Salamanca y Aladro].
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Atribución 4.0 Internacional